Skip to Content
  • Rank
    15
  • Previous Rank
    14
  • CEO
    John H. Hammergren
  • Address
    1 Post St., San Francisco, CA 94104
  • Website
    www.mckesson.com

The nation’s largest drug distributor dropped one spot on this year’s list after a decline in warehouse sales resulted in a slight revenue dip. McKesson’s profits also slipped last year — down 4.6% to $1.3 billion — but the company hopes to improve its earnings and reach through its purchase of Germany’s Celesio, one of Europe’s top drug wholesalers. The company also recently drew the ire of activist investors upset over CEO John Hammergren’s record-setting $159 million pension benefit. The company leader responded to the complaints by agreeing to cut $45 million from the lump-sum compensation.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Key Financials

$ Millions% change
Revenues122,455-0.2
Profits
1338
-4.6
Total Assets34,786-
Total Shareholder Equity7,070-
Market Value (on March 31, 2014)40,633-

Profit as a % of

Sales1.1
Assets3.8
Stockholders' Equity18.9

Earnings Per Share

Earnings Per Share ($)5.59
EPS % Change (from 2012)-
EPS % Change (5 year)11
EPS % Change (10 year)11.5

Total Return to Investors

Total Return to Investors67.7
Total Return to Investors (5 year, annualized)34.3
Total Return to Investors (10 year, annualized)
18.4